Acquity UPLC I-Class Plus
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new requirement for Acquity UPLC I-Class Plus analytical laboratory instruments to be deployed across four laboratories that analyze for undeclared and nonpermitted color additives in regulated products. This procurement seeks to upgrade detection capabilities with higher sensitivity and throughput to enhance the agency's analytical testing capacity. The estimated solicitation release date is January 1, 2026, with an anticipated award date of September 1, 2026.
The estimated award value for this contract ranges from $250,000 to $700,000, with the equipment being classified under NAICS 334516 (Analytical Laboratory Instrument Manufacturing). The procurement will support four separate FDA laboratories simultaneously, indicating a multi-site implementation. For inquiries regarding this opportunity, interested vendors should contact the Food and Drug Administration's Acquisition Liaison at hfpacquisitions@fda.hhs.gov.
Forecast text
Acquity UPLC I-Class Plus
This equipment will be used in all four labs that are analyzing for undeclared and nonpermitted color additives in regulated products, as part of our move to detection methods with higher sensitivity and throughput.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast